Background: Gestational diabetes mellitus is associated with significant fetal and neonatal morbidity and mortality. It is a definitive risk factor for the future development of type-II diabetes mellitus in the mother. Our objective was to evaluate the effectiveness of screening by 50 gm oral glucose challenge test to detect the gestational diabetes mellitus and impaired glucose tolerance in pregnant women.
Methods: This study was conducted in the Department of Gynaecology at Lady Reading Hospital, Peshawar. A total of 1000 women were screened in antenatal clinic by giving them 50 gm oral glucose solution and estimation of plasma glucose level 1 hour after glucose intake. Those with plasma glucose in excess of 130 mg/dl (cut off value for screen positive) were subjected to 3 hours oral glucose tolerance test to confirm the diagnosis of gestational diabetes mellitus.
Result: Out of 1000 cases tested, 43 were found to have Gestational Diabetes Mellitus and 17 cases had impaired glucose tolerance. The mean age of the patients ranged between 21 and 42 years. Most of the positive patients carried medical and obstetric historic risk factors for diabetes mellitus like obesity, advanced age and parity and bad obstetric history. They also had associated complications of gestational diabetes mellitus like pre eclampsia and polyhydramnios in current pregnancy. Also more than 80% of the patients had family history of risk factors like diabetics mellitus, obesity, hypertension etc.
Conclusions: 50 gm Oral Glucose Challenge Test can be used in pregnant ladies from 24 weeks onward to detect the common disorders of Gestational Diabetes Mellitus and Impaired Glucose Tolerance.
Download full-text PDF |
Source |
---|
Am J Manag Care
January 2025
McGovern Medical School at UTHealth Houston, 4513 Teas St, Bellaire, TX 77401.
Objective: To examine the effect of physiologic insulin resensitization (PIR) on the cost of treating patients with diabetes and chronic kidney disease (CKD).
Study Design: The mean 1-year cost of treating 66 Medicare Advantage patients with diabetes and CKD who were receiving PIR was compared with that of treating 1301 Medicare Advantage patients with diabetes and CKD not receiving PIR. Differences in disease severity were compared using mean risk adjustment factor scores.
Am J Manag Care
January 2025
Ascension Borgess Hospital, 345 Naomi St, Plainwell, MI 49080. Email:
Objective: To describe the outcomes of a partnership between a drug plan and pharmacists to switch patients from brand name dipeptidyl-peptidase-4 inhibitors to the generic alogliptin.
Study Design: Single-center, retrospective chart review.
Methods: Clinical pharmacists contacted patients with primary care providers within the health system affiliated with the drug plan to facilitate the switch.
Health Syst Reform
December 2025
Independent Consultant, Alexandria, VA, USA.
For over 50 years, health systems the world over have failed people with type 2 diabetes mellitus (T2DM). The WHO documents a quadrupling of people with diabetes in a 34-year period to 422 million in 2014, the overwhelming majority of whom were T2DM. This happened despite extensive scientific literature on the causes of, as well as proven treatments for, this disease.
View Article and Find Full Text PDFN Z Med J
January 2025
Department of Public Health, University of Otago, Wellington, Aotearoa New Zealand.
Background: The prevalence of diabetes has been increasing in Aotearoa New Zealand by approximately 7% per year, and is three times higher among Māori and Pacific peoples than in Europeans. The depth of the diabetes epidemic, and the expansive breadth of services required for its management, elevate the need for high-quality evidence on the projected future burden of this complex disease.
Methods: In this manuscript we have projected the prevalence of diabetes (type 1 and type 2 combined) out to 2040-2044 using age-period-cohort modelling.
Biomol Biomed
January 2025
Department of Otorhinolaryngology and Head and Neck Surgery, The Affiliated Zhuzhou Hospital Xiangya Medical College CSU, Zhuzhou, China.
Diabetes mellitus (DM) has been suggested as a potential risk factor for tinnitus, but evidence remains inconclusive. This meta-analysis aimed to evaluate the association between DM and tinnitus by systematically reviewing and synthesizing data from observational studies. A comprehensive literature search was conducted in PubMed, Embase, and Web of Science up to August 16, 2024.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!